Skip to content

The effect of "Gharasaneh" Syrup on Dysmenorrhea

The Effect of Eryngium Syrup on Primery Dysmenorrhea and comparison with Ibuprofen Syrup; Clinical Control Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015082823789N1
Enrollment
150
Registered
2015-11-18
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysmenorrhoea. Primary dysmenorrhoea

Interventions

Intervention 1: "Gharasaneh" syrup
it will be prescribed 3 days before probable bleeding time up to the 3rd day of bleeding. The dosage is 10 ml TDS. The treatment is continued for 2 consecutive cycles. Intervention 2: Ibuprofen syrup
it will be prescribed 3 days before probable bleeding time up to the 3rd day of bleeding. The dosage is 10 ml TDS. The treatment is continued for 2 consecutive cycles. Intervention 3: Placebo syrup
it will be prescribed 3 days before probable bleeding time up to the 3rd day of bleeding. The dosage is 10 ml TDS. The treatment is continued for 2 consecutive cycles.
Treatment - Drugs
"Gharasaneh" syrup
Ibuprofen syrup (200mg/5cc)

Sponsors

Babol University of Medical Scienses
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Age between 18 to 30; Primary dysmenorrhea (pain is started 1 to 2 years after menarche during the menstruation and dose not appear any other time) exclusion criteria:Heavy exercise; Taking other drugs during the study; Concomitant use of hormonal contraceptive methods; History of allergy to herbal medicine; Severe stress (Such as the loss of a close relative, Intense familial debate, some other stress factor during recent 6 months)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: Before intervention, 2 month after begining intrvention. Method of measurement: Visual Analogue scale.;Severity of pain. Timepoint: first menstural cycle after study. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Behmanesh

Babol University of Medical Sciences

e.behmanesh@mubabol.ac.irbehmanesh_e@yahoo.com+98 11321995926

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026